Financials
- Market Capitalization 22 M
- Employee 115
- Founded 1998
- CEO N/A
- Website www.celularity.com
- Headquarter Delaware, United States
- FIGI BBG00P2RTT34
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4564 | NRSN NeuroSense Therapeutics Ltd. - Ordinary Shares | 0.72 USD | -1.37% | +4.35% | -4.00% | -64.00% | 23.44 M USD | ||
| 4588 | KZIA Kazia Therapeutics Limited - American Depositary Shares | 13.48 USD | -0.81% | +5.97% | -7.42% | +130.43% | 21.82 M USD | ||
| 4592 | ALGS Aligos Therapeutics, Inc. - Common stock | 6.42 USD | +0.94% | +6.82% | +21.13% | -34.42% | 22.24 M USD | ||
| 4595 | VYNE VYNE Therapeutics Inc. - Common Stock | 0.71 USD | +7.58% | +5.97% | +9.23% | -46.21% | 23.68 M USD |
Frequently asked questions about Celularity Inc. - Class A Common Stock
What is the Celularity Inc. - Class A Common Stock stock price today?
The current price of Celularity Inc. - Class A Common Stock (CELU) is 0.76. Over the past 24 hours, the stock has changed by 0.00%. Follow the CELU chart for real-time price dynamics.
What is the stock ticker of Celularity Inc. - Class A Common Stock?
Celularity Inc. - Class A Common Stock trades under the ticker CELU. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Celularity Inc. - Class A Common Stock stock going up?
CELU has changed by +4.11% over the last week, -5.00% over the last month, and -68.60% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Celularity Inc. - Class A Common Stock net income for the last quarter?
Celularity Inc. - Class A Common Stock reported net income of -24.36 M for the last quarter. The previous quarter showed -23.08 M, which means net income changed by -5.57%.
How many employees does Celularity Inc. - Class A Common Stock have?
As of the latest available data, Celularity Inc. - Class A Common Stock has 115 employees. Workforce size can provide additional context about the company's scale and operations.
What is Celularity Inc. - Class A Common Stock EBITDA?
Celularity Inc. - Class A Common Stock EBITDA is -23.25 M, and its EBITDA margin is -566.54%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Celularity Inc. - Class A Common Stock stock?
You can buy Celularity Inc. - Class A Common Stock (CELU) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Celularity Inc. - Class A Common Stock stock?
Investing in Celularity Inc. - Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CELU chart and related analysis on metatrader.com as part of your research.